Andy Berlin, a Silicon Valley veteran, will tell you his research group is not going to be jumping into the DNA array business any time soon.

There are many reasons to believe that to be true. His employer is Intel and the estimated $500 million microarray market might be a bit to small for the global semiconductor giant, which has 83,000 employees and revenues of $27 billion for 2002.

However, with the high-tech market in tatters, the emerging microarray market appears enticing, and, down the road, so too is the diagnostics market.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.